Responses
Regular and young investigator award abstracts
Clinical trials in progress
329 Prolonged overall survival (OS) in patients with metastatic colorectal cancer (mCRC) in SPICE, a phase I study of enadenotucirev in combination with nivolumab
Compose a Response to This Article
Other responses
No responses have been published for this article.
